Phase I study of bortezomib plus ICE (BICE) for the treatment of relapsed/refractory Hodgkin lymphoma.

Authors :: Fanale, Michelle
Fayad, Luis
Pro, Barbara
Samaniego, Felipe
Liboon, Mary Joy
Nunez, Cesar
Horowitz, Sandra
Anderlini, Paolo
Popat, Uday
Ji, Yuan
Kwak, Larry W.
Younes, Anas
Source :: British Journal of Haematology; Jul2011, Vol. 154 Issue 2, p284-286, 3p, 1 Chart, 1 Graph
Publication Year :: 2011
Abstract: The article offers information on Classical Hodgkin lymphoma (HL). It discusses the causes for the development of relapsed or refractory disease in the patients. The treatment for Hodgkin lymphoma through bortezomib plus ifosfamide, carboplatin, etoposide (BICE) has also been discussed in the article.

Subjects :: HODGKIN'S disease treatment
LYMPHOMAS
ANTINEOPLASTIC agents
ETOPOSIDE
PATHOLOGY

Full Text Access

Tools